Bill Ackman Jumps Deeper Into Toxic Valeant Pharmaceuticals With Board Nominee |
| March 10, 2016 | March 2016 Bond Updates |
|
As the third biggest shareholder in Valeant Pharmaceuticals, Bill Ackman has an ambivalent prognosis on the company's current woes. |
| View more at: http://www.forbes.com/sites/antoinegara/2016/03/09/bill-ackman-sews-closer-ties-to-toxic-valeant-pharmaceuticals-with-board-nominee/ |
| Related News |
|